효성화학 298000

http://comp.fnguide.com/SVO2/asp/SVD_Main.asp?pGB=1&gicode=A298000&cID=&MenuYn=Y&ReportGB=&NewMenuID=101&stkGb=701

효성화학(A298000) | Snapshot | 기업정보 | Company Guide

- 아직 어두운 터널을 지나는 중 매수(유지) 현재주가 (4/ 26) 56,700 원 TP 90,000원 (하향)
  상승여력 58.7% - 신한투자 - 2024.04.29 1714348747061.pdf (pstatic.net)
- 아직 터널 안 NOT RATED 주가(3/5): 67,000 원 -
  키움증권 - 2024.03.06 1709681338732.pdf (pstatic.net)
- 베트남 탐방을 통해 재확인된 성장 기회 매수(유지)  현재주가 (11 월 20 일) 92,400 원 
  TP120,000 원 (유지) 여력 29.9% - 신한투자 - 2023.11.21 1700522574309.pdf (pstatic.net)
- 베트남 법인, 분기 첫 영업흑자 달성 매수(유지)  주가 (10 / 27 ) 87,200 원 
  TP120,000 원 (유지)  상승여력  37.6% - 신한투자 - 2023.10.30 1698628997559.pdf (pstatic.net)
- 본업 적자에 가려진 “고밸류 가스” 성장 Buy(유지) 목표주가(하향): 230,000원 
  현재 주가(9/1) 168,000원  상승여력 ▲36.9% -  
  한화증권 - 2022.09.02 analysis.downpdf (hankyung.com)
- PP/DH는 부진. NF3 마진 대폭 개선과 폴리케톤 흑전 임박 주목 BUY TP(12M): 290,000원(하향)
  CP(4월27일): 228,500원 -  하나대투 - 2022.04.28  2013년 0월 0일 (hanaw.com)
- 희망의 눈높이는 상반기보다 하반기로 Buy(Maintain) 목표주가(12M) 370,000원(하향)
  종가(2022/04/04) 263,500원 상승여력 40.4 % -  
  하이투자 - 2022.04.05 Underweight EM Equity (hankyung.com)
- 분기 적자로 고PER 상태. 시클리컬은 고PER에 매수 BUY I TP(12M): 370,000원(하향)
   CP(1월26일): 284,000원 -  하나대투 - 2022.01.27 2013년 0월 0일 (hanaw.com)
- NF3 가격, 고공행진 중 BUY(Maintain) TP 500,000원 주가(1/12): 348,500원 -
  키움증권 - 2022.01.13 analysis.downpdf (hankyung.com)
- 2022년에는 좋은 일만 가득할거예요 Buy(Maintain) 목표주가(12M) 500,000원(유지)
  종가(2022/01/11) 351,500원 상승여력 42.2 %-  
  하이투자 - 2022.01.12 Underweight EM Equity (hankyung.com)
- 모두가 기다린 2022년 Buy(유지) 목표주가(유지): 370,000원 주가(12/30) 303,500원 
  상승여력 ▲21.9% -  한화증권 - 2022.01.03  analysis.downpdf (hankyung.com)
- 폴리케톤, 올해 EBITDA 흑자전환 전망 BUY(Maintain) 목표주가: 460,000원 
  현재주가(12/02): 291,500원 -  키움증권 - 2021.12.03 analysis.downpdf (hankyung.com)
- SK머티리얼즈 합병의 투자대안 BUY TP(12M): 700,000원 CP(8월25일): 358,000원 -
  하나대투 -2021.08.26 
https://www.hanaw.com/download/research/FileServer/WEB/industry/enterprise/2021/08/25/HS_Chemical_3Q21_Pre_20210826_Final.pdf
- 베트남 PP/DH 가동 직전에 기록한 사상 최대 실적 BUY I TP(12M): 700,000원 
   CP(7/30): 392,500원 -  하나대투 - 2021.08.02 
https://www.hanaw.com/download/research/FileServer/WEB/industry/enterprise/2021/07/30/HSC_2Q21_Review_20210802_Final_0.pdf
- 목표시총 2.2조원. 프리미엄 PP 시장과 NF3에 주목 BUY TP 700,000원(상향) 
  CP(4월30일): 405,000원 -  하나대투 - 2021.05.03 
www.hanaw.com/download/research/FileServer/WEB/industry/enterprise/2021/05/01/HSC_1Q21_Review_20210503.pdf
- 베트남 PDH 가동에 이익급증 전망…목표가↑-대신증권 - 2021.04.19
  news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=001&oid=031&aid=0000593830
- 전 사업부문 실적 개선…1Q 영업익 전망치 웃돌 전망-키움證 - 2021.03.22
  news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=001&oid=031&aid=0000589135
- 1Q21부터 서프라이즈. 중장기 높은 투자수익률 가능 영역 BUY I TP(12M): 370,000원(상향) 
  CP(3월12일): 236,000원 - 하나대투 - 2021.03.15 
www.hanaw.com/download/research/FileServer/WEB/industry/enterprise/2021/03/14/HSC_1Q21_Preview_210315_0_1.pdf
- 2020년의 부진은 2021년에 큰 보상으로 되돌아 온다 BUY I TP(12M): 200,000원 
  CP(10월 30일): 126,000원 - 하나대투 - 2020.11.02 
www.hanaw.com/download/research/FileServer/WEB/industry/enterprise/2020/11/01/HSC_3Q20%20Review_20201102.pdf
- 어닝은 쇼크지만 2021년 PER은 3배 투자의견 BUY 매수, 유지 6개월 목표주가 155,000 유지
  현재주가 (07.31) 107,000 - 대신증권 - 2020.08.03
  consensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=567469
- 2Q Re. 핵심 투자 포인트 이상 무 Buy 유지 TP 175,000 원 유지 현재가(07/31) 107,000 원 -
  교보증권 - 2020.08.03  
  consensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=567574
- 단기 부진 불구, 2020년 이후에 대한 긍정적인 시각 유지 BUY I TP(12M): 170,000원(하향)
  CP(7월 31일): 107,000원 -   하나데투 - 2020.08.03 HSC_2Q20 Review_20200803.pdf 
- 상반기 부진을 가슴에 묻고 BUY(유지) 목표주가 유지 157,000원 현재주가 (07/17) 109,500원
  Up/Downside +43.4% - DB금융 - 2020.07.20
  consensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=566347
- 단기 부진에도 싸다고 느껴지는 이유 투자의견 BUY 매수, 유지 6개월 TP 155,000유지 
  현재주가 (20.07.08)  105,500 - 대신증권 - 2020.07.09
  consensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=565507
- PDH 경쟁력 회복 구간 BUY(유지) 목표주가 유지 157,000 원 현재주가 (05/22) 115,500원
  Up/Downside +35.9% - DB금융 - 2020.05.25
  consensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=561482
- PP 스프레드, 2분기부터 본격적인 개선 전망 BUY(Maintain) TP 180,000원 
  현재주가(05/20): 113,000원 - 키움증권 -  2020.05.21
  http://consensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=561110
- 적정 주가까지는 아직도 갈 길이 멀다 BUY(유지) 목표주가 상향 157,000원 
  현재주가 (04/ 115,000원  Up/Downside +36.5% -DB금융 - 2020.05.04
  http://consensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=558982
- 1Q RE. 레버리지를 활용한 PP/DH의 수익 극대화 Buy 유지 TP 175,000 원  
  현재가(04/29) 115,000 원 -  교보증권 -  2020.05.04
  http://consensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=559037
- 마스크 수혜와 원재료 절감의 두 마리 토끼 Buy 유지 TP 175,000 원 상향 
  현재가(04/23) 111,500 원 -  교보증권 - 2020.04.27
  http://consensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=558308
- PP/DH의 높은 수익성 확읶. 1Q20은 프로판 가격 상승 부담 BUY I TP(12M): 200,000원(하향) 
  CP(1월 10읷): 128,500원 - 하나대투 - 2020.01.13
  http://consensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=548246
- 非석유화학부문 Multiple 상승, 소형 Top-Pick 추천 Buy 유지 TP 200,000원  
  현재주가(02/01) 152,000 원 -  교보증권 - 2019.02.07
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=512160
- 우호적인 업황 & 차별화된 성장성. 매수 유망 투자의견 BUY 유지 TP 220,000 
  현재가(1/10) 150,500원-  KTB투자- 2019.01.11
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=508430
- 투자 포인트 : PP, 수급 타이트 지속 BUY (Initiate) 주가(8/31): 189,000원/TP: 276,000원 -
  키움증권 - 2018.09.03 
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=491911
- NF3의 가치가 전혀 반영되지 않은 시총. 목표시총 9천억 제시 BUY TP(12M): 280,000(신규) 
  CP(8월 28일): 160,000원 - 하나대투 - 2018.08.29
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=491447